Blog
Acromegaly Guide for Building a Support Group
PNA Medical Corner: Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomized, phase 3 trial
The third PNA Medical Corner for this month focuses on a study co-authored by PNA member Dr. Maria Fleseriu and a longtime friend of the PNA, Dr. Annamaria Colao. It looks at several medical treatments for acromegaly.
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
Gadelha MR, Bronstein MD, Brue T, Coculescu M, Fleseriu M, Guitelman M, Pronin V, Raverot G, Shimon I, Lievre KK, Fleck J, Aout M, Pedroncelli AM, Colao A; on behalf of the Pasireotide C2402 Study Group.
Lancet Diabetes Endocrinol. 2014 Sep 23. pii: S2213-8587(14)70169-X. doi: 10.1016/S2213-8587(14)70169-X. [Epub ahead of print]
Mixed Martial Arts Fighter Battles Acromegaly
Mixed Martial Arts (MMA) fighter Antonio Silva had transsphenoidal surgery in Sao Paolo, Brazil in late September to combat a recurrence of a pituitary tumor causing acromegaly, according to an article in MMAfighting.com. The site also quotes his manager, Alex Davis, as saying "The surgery was a success. It's a head surgery, so it's always complicated. They had to access the gland under the brain through the nose, so it's not a simple surgery – especially for a fighter, who gets punched in the face for a living." Silva was knocked out in a recent fight. Davis said, "He should get cleared to train again in two months," Davis said. "I think he will be ready to fight in five or six months. He wants to fight again. He's disappointed with his last fight."
Emory - Patient Symposium and Awards Dinner
You Are Invited!!
Free Pituitary Education Day &
Gentle Giant Award Reception
September 27, 2014
1:30 PM - 7:00 PM